H5 DNA疫苗对鸡高致病性禽流感的保护效果:免疫程序的影响
研究评估编码clade 2.3.4.4c H5基因的DNA疫苗在SPF白来航鸡中对同源和异源H5高致病性禽流感病毒的保护效果,比较2周龄单剂、2周龄首免4周龄加强及是否加佐剂的免疫程序。含佐剂两剂组对同源和异源攻击均获完全临床保护并显著或完全减少排毒,免疫持续至18或25周龄。
要点
- 含佐剂两剂组对同源和异源clade 2.3.4.4b攻击均获完全临床保护。
- 单剂加或不加佐剂及两剂加佐剂组显著或完全减少同源攻击后排毒。
- 两剂加佐剂组哨兵鸡完全免于死亡且未检出排毒。
核心结论
- H5 DNA疫苗效力研究证实这类第三代疫苗可在抗击H5高致病性禽流感病毒中发挥重要作用。
研究设计与样本
- 在SPF白来航鸡中评估编码clade 2.3.4.4c H5基因(A/gyrfalcon/Washington/41088-6/2014株)的新型DNA疫苗对同源和异源H5高致病性禽流感病毒的保护效果。
- 比较2周龄单剂(1剂)与2周龄首免、4周龄加强(2剂),加或不加佐剂。
主要发现
- 单剂加或不加佐剂组及两剂加佐剂组在6和25周龄同源攻击中获完全临床保护并显著或完全减少排毒。
- 6周龄鸡两剂加或不加佐剂对异源clade 2.3.4.4b攻击显示类似结果,表明DNA疫苗诱导良好交叉保护。
- 接种鸡观察到持久体液免疫至18或25周龄,取决于免疫程序。
- 同源攻击后传播分析显示,两剂加佐剂组哨兵鸡完全免于死亡且未检出排毒。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
H5 highly pathogenic avian influenza (HPAI) viruses of the Asian lineage (A/goose/Guangdong/1/96) belonging to clade 2.3.4.4 have spread worldwide through wild bird migration in two major waves: in 2014/2015 (clade 2.3.4.4c), and since 2016 up to now (clade 2.3.4.4b). Due to the increasing risk of these H5 HPAI viruses to establish and persist in the wild bird population, implementing vaccination in certain sensitive areas could be a complementary measure to the disease control strategies already applied. In this study, the efficacy of a novel DNA vaccine, encoding a H5 gene (A/gyrfalcon/Washington/41088-6/2014 strain) of clade 2.3.4.4c was evaluated in specific pathogen-free (SPF) white leghorn chickens against a homologous and heterologous H5 HPAI viruses. A single vaccination at 2 weeks of age (1 dose), and a vaccination at 2 weeks of age, boosted at 4 weeks (2 doses), with or without adjuvant were characterized. The groups that received 1 dose with or without adjuvant as well as 2 doses with adjuvant demonstrated full clinical protection and a significant or complete reduction of viral shedding against homologous challenge at 6 and 25 weeks of age. The heterologous clade 2.3.4.4b challenge of 6-week-old chickens vaccinated with 2 doses with or without adjuvant showed similar results, indicating good cross-protection induced by the DNA vaccine. Long lasting humoral immunity was observed in vaccinated chickens up to 18 or 25 weeks of age, depending on the vaccination schedule. The analysis of viral transmission after homologous challenge showed that sentinels vaccinated with 2 doses with adjuvant were fully protected against mortality with no excretion detected. This study of H5 DNA vaccine efficacy confirmed the important role that this type of so-called third-generation vaccine could play in the fight against H5 HPAI viruses.
引用
- Valentin J, Ingrao F, Rauw F, et al. Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules. Vaccine. 2024. PMID: 38350766. doi:10.1016/j.vaccine.2023.11.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。